Journal ArticleOPEN ACCESS

Successful topical rapamycin treatment for facial angiofibromata in two children

Pediatric Dermatology (2015) 32(3) e120-e123
DOI: 10.1111/pde.12551
14Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Topical sirolimus, or rapamycin, is known to inhibit tumorigenesis in tuberous sclerosis. We report two cases of successful treatment of children with facial angiofibromata and summarize the encouraging evidence of the effectiveness of this therapy in the literature.

Cite

CITATION STYLE

APA

Pynn, E. V., Collins, J., Hunasehally, P. R. Y., & Hughes, J. (2015). Successful topical rapamycin treatment for facial angiofibromata in two children. Pediatric Dermatology, 32(3), e120–e123. https://doi.org/10.1111/pde.12551

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free